BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28373828)

  • 21. MicroRNA-146a regulates cisplatin-resistance of non-small cell lung cancer cells by targeting NF-κB pathway.
    Jiang P; Jia W; Wei X; Zhang X; Wang C; Li B; Song T; Yang J; Zhu D; Meng Y
    Int J Clin Exp Pathol; 2017; 10(12):11545-11553. PubMed ID: 31966510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach.
    Miranda J; Bringas R; Fernandez-de-Cossio J; Perera-Negrin Y
    Mol Med; 2021 Dec; 27(1):161. PubMed ID: 34930105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation.
    Perea SE; Baladrón I; Valenzuela C; Perera Y
    Semin Oncol; 2018 Jan; 45(1-2):58-67. PubMed ID: 30318085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1.
    Daghero H; Fernández Massó JR; Astrada S; Guerra Vallespí M; Bollati-Fogolín M
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling.
    Parhar K; Morse J; Salh B
    Int J Colorectal Dis; 2007 Jun; 22(6):601-9. PubMed ID: 17009010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.
    Fernández Massó JR; Oliva Argüelles B; Tejeda Y; Astrada S; Garay H; Reyes O; Delgado-Roche L; Bollati-Fogolín M; Vallespí MG
    J Amino Acids; 2013; 2013():251398. PubMed ID: 23401744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
    Karthik S; Sankar R; Varunkumar K; Anusha C; Ravikumar V
    Biomed Pharmacother; 2015 Feb; 69():337-44. PubMed ID: 25661379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis.
    Perera Y; Pedroso S; Borras-Hidalgo O; Vázquez DM; Miranda J; Villareal A; Falcón V; Cruz LD; Farinas HG; Perea SE
    Mol Cell Biochem; 2015 Jun; 404(1-2):103-12. PubMed ID: 25805179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection.
    Ramón AC; Pérez GV; Caballero E; Rosales M; Aguilar D; Vázquez-Blomquist D; Ramos Y; Rodríguez-Ulloa A; Falcón V; Rodríguez-Moltó MP; Yang K; Perera Y; Perea SE
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells.
    Li Q; Zong Y; Li K; Jie X; Hong J; Zhou X; Wu B; Li Z; Zhang S; Wu G; Meng R
    Biol Res; 2019 Apr; 52(1):22. PubMed ID: 30992075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of stable reporter breast and lung cancer cell lines for NF-κB activation studies.
    Daghero H; Pagotto R; Vallespí MG; Bollati-Fogolín M
    J Biotechnol; 2019 Aug; 301():79-87. PubMed ID: 31145935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues.
    Qaiser F; Trembley JH; Sadiq S; Muhammad I; Younis R; Hashmi SN; Murtaza B; Rector TS; Naveed AK; Ahmed K
    Mol Cell Biochem; 2016 Sep; 420(1-2):43-51. PubMed ID: 27435858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway.
    Zhu J; Xin Y; Liu X; Wang Y; Liu Y
    Exp Ther Med; 2018 Apr; 15(4):3345-3351. PubMed ID: 29545853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway.
    Li Y; Qi K; Zu L; Wang M; Wang Y; Zhou Q
    Thorac Cancer; 2016 Mar; 7(2):190-8. PubMed ID: 27042221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects.
    Zanin S; Sandre M; Cozza G; Ottaviani D; Marin O; Pinna LA; Ruzzene M
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1694-707. PubMed ID: 25936516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.